VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ASMB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ASMBAssembly Biosciences, Inc.
$22.50$446M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksASMBQuarterly Financials

Assembly Biosciences, Inc. (ASMB) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Assembly Biosciences, Inc. (ASMB) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

ASMB Income Statement

Quarterly statement

ASMB Income Statement

Assembly Biosciences, Inc. (ASMB) annual income statement — 18-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue2.96M13.37M8.21M42.47M10.79M9.63M9.42M7.36M6.84M8.53M5.79M7.16M00000000
Revenue Growth %-72.6%38.94%-12.8%477.26%57.62%12.81%62.82%2.71%---------100%---100%
Cost of Goods Sold020K26K32K16.59M16.13M14.85M14.28M13.52M32K32K84K10.82M12.52M14.55M17.25M17.43M17.29M17.2M12.27M
COGS % of Revenue-0.15%0.32%0.08%153.74%167.52%157.67%194.1%197.44%0.38%0.55%1.17%--------
Gross Profit2.96M13.35M8.19M42.44M-5.8M-6.5M-5.43M-6.92M-6.67M8.5M5.75M7.08M-10.82M-12.52M-14.55M-17.25M-17.43M-17.29M-17.2M-12.27M
Gross Margin %100%99.85%99.68%99.92%-53.74%-67.52%-57.67%-94.1%-97.44%99.63%99.45%98.83%--------
Gross Profit Growth %150.98%305.48%250.72%712.99%13.07%-176.45%-194.42%-197.8%38.38%167.88%139.55%141.03%37.9%27.58%15.45%-40.59%-42.63%-3.24%7.27%54.52%
Operating Expenses26.37M19.7M19.58M22.67M5.08M4.59M4.51M4.61M4.29M20.7M16.48M19.63M4.22M4.96M5.01M5.72M5.97M7.28M5.96M50.62M
OpEx % of Revenue892.12%147.29%238.44%53.38%47.13%47.72%47.87%62.65%62.61%242.63%284.91%274.05%--------
Selling, General & Admin6.14M4.8M4.68M5.42M5.08M4.59M4.51M4.61M4.29M4.45M4.6M8.62M4.22M4.96M5.01M6.42M5.17M6.28M5.96M6.23M
SG&A % of Revenue207.61%35.9%57.02%12.76%47.13%47.72%47.87%62.65%62.61%52.09%79.57%120.4%--------
Research & Development20.23M14.92M14.9M17.25M16.59M16.13M14.85M14.28M13.52M16.26M11.88M11.01M10.82M12.52M14.55M16.85M18.13M17.79M17.2M14.75M
R&D % of Revenue684.51%111.54%181.42%40.62%153.74%167.52%157.67%194.1%197.44%190.54%205.34%153.65%--------
Other Operating Expenses0-20K00-1000K-1000K-1000K-1000K-1000K000-1000K-1000K-1000K-1000K-1000K-1000K-1000K1000K
Operating Income-23.41M-6.34M-11.37M19.8M-10.88M-11.09M-9.94M-11.53M-10.96M-12.2M-10.73M-12.55M-15.05M-17.49M-19.56M-22.98M-23.4M-24.57M-23.16M-62.89M
Operating Margin %-792.12%-47.44%-138.44%46.62%-100.87%-115.24%-105.54%-156.75%-160.06%-143.01%-185.46%-175.22%--------
Operating Income Growth %-115.15%42.81%-14.37%271.69%0.67%9.1%7.34%8.12%27.19%30.22%45.15%45.38%35.7%28.83%15.56%63.46%-23.98%-3.83%15.03%-58.64%
EBITDA-23.39M-6.32M-11.34M19.83M-10.85M-11.06M-9.91M-11.5M-10.92M-12.17M-10.7M-12.47M-14.93M-17.36M-19.43M-22.85M-23.27M-24.45M-23.04M-62.77M
EBITDA Margin %-791.31%-47.29%-138.12%46.7%-100.57%-114.91%-105.19%-156.31%-159.58%-142.63%-184.91%-174.05%--------
EBITDA Growth %-115.57%42.83%-14.49%272.44%0.66%9.12%7.38%7.76%26.85%29.9%44.96%45.45%35.82%29%15.65%63.59%-24.05%-3.85%15.13%-59.6%
D&A (Non-Cash Add-back)24K20K26K32K32K32K33K32K33K32K32K84K116K126K124K124K134K120K120K120K
EBIT-20.26M-3.86M-9.08M22.09M-9.2M-10.2M-8.82M-10.26M-9.61M-10.75M-9.08M-10.93M-15.05M-17.49M-19.56M-23.68M-22.6M-23.57M-23.16M-18.5M
Net Interest Income3.16M2.49M2.29M2.29M1.69M895K1.12M1.12M1.34M1.46M1.65M1.62M628K592K609K583K256K112K71K101K
Interest Income3.16M2.49M2.29M2.29M1.69M895K1.12M1.12M1.34M1.46M1.65M1.62M628K592K609K583K256K112K71K101K
Interest Expense00000000000000000000
Other Income/Expense3.16M2.49M2.29M2.29M1.69M895K1.12M1.27M1.34M1.46M1.65M1.62M628K592K609K583K256K112K71K101K
Pretax Income-20.26M-3.86M-9.08M22.09M-9.2M-10.2M-8.82M-10.26M-9.61M-10.75M-9.08M-10.93M-14.42M-16.9M-18.95M-22.39M-23.14M-24.46M-23.09M-62.79M
Pretax Margin %-685.25%-28.84%-110.54%52.01%-85.23%-105.94%-93.62%-139.45%-140.44%-125.93%-156.91%-152.58%--------
Income Tax000000076K0406K033K0000000-2.53M
Effective Tax Rate %0%0%0%0%0%0%0%-0.74%0%-3.78%0%-0.3%0%0%0%0%0%0%0%4.03%
Net Income-20.26M-3.86M-9.08M22.09M-9.2M-10.2M-8.82M-10.34M-9.61M-11.15M-9.08M-10.96M-14.42M-16.9M-18.95M-22.39M-23.14M-24.46M-23.09M-60.26M
Net Margin %-685.25%-28.84%-110.54%52.01%-85.23%-105.94%-93.62%-140.48%-140.44%-130.69%-156.91%-153.04%--------
Net Income Growth %-120.27%62.18%-2.96%313.74%4.34%8.55%2.85%5.72%33.34%34%52.1%51.05%37.7%30.93%17.93%62.83%-23.09%-3.67%15.11%-52.87%
Net Income (Continuing)-20.26M-3.86M-9.08M22.09M-9.2M-10.2M-8.82M-10.34M-9.61M-11.15M-9.08M-10.96M-14.42M-16.9M-18.95M-22.39M-23.14M-24.46M-23.09M-60.26M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.93-0.20-0.542.49-1.20-1.33-1.17-1.72-1.51-1.98-1.66-2.00-3.29-3.88-4.31-5.32-4.70-5.00-4.80-13.20
EPS Growth %22.5%84.96%53.85%244.77%20.53%32.83%29.52%14%54.1%48.97%61.48%62.41%30%22.4%10.21%59.7%-14.63%9.09%30.43%-57.95%
EPS (Basic)-0.93-0.20-0.542.49-1.20-1.33-1.17-1.72-1.51-1.98-1.66-2.00-3.29-3.88-4.31-5.32-4.70-5.00-4.80-13.40
Diluted Shares Outstanding21.78M18.85M16.9M11.21M7.66M7.66M7.51M6.58M6.35M5.64M5.48M5.48M4.38M4.36M4.25M4.07M4.84M4.83M4.81M4.56M
Basic Shares Outstanding21.78M18.85M16.9M11.21M7.66M7.66M7.51M6.58M6.35M5.64M5.48M5.48M4.38M4.36M4.25M4.07M4.84M4.83M4.81M4.49M
Dividend Payout Ratio--------------------